MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Visual Motion Perception and Metacognition in Parkinson’s disease

O. Halperin, R. Karni, S. Israeli-Korn, S. Hassin-Baer, A. Zaidel (Ramat Gan, Israel)

Meeting: MDS Virtual Congress 2020

Abstract Number: 673

Keywords: Cognitive dysfunction, Parkinsonism, Visuospatial deficits

Category: Parkinson's Disease: Neurophysiology

Objective: To investigate visual motion perception as a potential contributor to impaired visual self-motion perception in PD. To measured metacognitive ability and bias in PD when estimating their own perceptual function.

Background: Impaired sensory and perceptual processes are understudied aspects of Parkinson’s disease (PD). Recently our group has shown impaired self-motion perception in PD specific to the visual modality as well as overweighting of this modality in multi-sensory perception.

Method: The participants (N=20 PD patients, N=20 aged-matched and N=20 young healthy controls) were required to determine the aggregate motion of dots (rightward/leftward) in a two-alternative forced choice task in a computer monitor (visual stimuli comprised 2D random dot kinematogram (RDK) of varying coherence). After each RDK discrimination, participants also indicated their confidence level (low/high) in their decision (Figure 1). For cognitive function control, we evaluated all subjects using the Montreal Cognitive Assessment test.

Results: Patients with PD did not have different visual motion thresholds in comparison to the control groups (p=0.11). Despite comparable RDK thresholds, PD patients exhibited higher confidence in their choices vs. each of the control groups (p≤0.02). No significant difference in cognitive function was seen between the PD and control groups (p= 0.06). See Figure 2 for example single subject results and Figure 3 for group results.

Conclusion: Our finding that PD patients did not show an impairment of 2D visual motion perception, suggests that our previous finding of impaired 3D visual self-motion perception is not due to a general impairment of visual motion perception. In addition, our finding of overconfidence in visual performance in PD patients might underlie accounts of increased visual dependency in PD. To assess whether perceptual confidence is generally increased in PD (vs. vision specific), metacognition needs to be tested also using other cues and tasks.

Fig 2 MSI

Fig 1 MSI

Fig 3 MSI

To cite this abstract in AMA style:

O. Halperin, R. Karni, S. Israeli-Korn, S. Hassin-Baer, A. Zaidel. Visual Motion Perception and Metacognition in Parkinson’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/visual-motion-perception-and-metacognition-in-parkinsons-disease/. Accessed May 10, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/visual-motion-perception-and-metacognition-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley